The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products

Summary

Single-center open-label multiple dose randomized two period cross-over study to examine Advanced Glycation End Product (AGE) levels in human subjects pre and post empagliflozin administration.

Timeline

Start

2017-12-01

Primary completion

2018-08

Completion

2018-12

Outcome

Outcome not reported

Stopped (Business): “no funding”

Drugs

Indications